Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Angiotensin blockers/ACE

Until recently, the cardiotonics and a diuretic were the treatment of choice for HE However, other dragp such as the angiotensin-converting enzyme (ACE) inhibitors, and beta blockers have become the treatment of choice during the last several years. See Figure 39-1 for an example of a method of determining treatment for left ventricular systolic dysfunction. See Chapters 23, 42, and 46 for more information on the beta blockers, ACE inhibitors, and diuretics, respectively. [Pg.358]

SSRI = selective serotonin reuptake inhibitor SNRI = serotonin norepinephrine reuptake inhibitor ARB = angiotensin receptor blocker ACE = angiotensin converting enzyme COX-2 = cyclooxygenase 2 ADHD = attention deficit hyperactivity disorder. [Pg.22]

Inhibition of the renin-angiotensin system (ACE inhibitors and angiotensin II receptor blockers]... [Pg.291]

BETA-BLOCKERS ACE INHIBITORS, ADRENERGIC NEURONE BLOCKERS, ANGIOTENSIN II RECEPTOR ANTAGONISTS t hypotensive effect Additive hypotensive effect may be used therapeutically Monitor BP at least weekly until stable. Warn patients to report symptoms of hypotension (light-headedness, dizziness on standing, etc.)... [Pg.69]

In the patient with chronic angina, the drugs commonly used seem to offer important myocardial protection Thus, (3-blockers, ACE inhibitors and most probably angiotensin receptor blockers, statins, Ca2+ channel blockers, all are in their way cardioprotective. Nitrates and more importantly nicorandil are worthwhile options. Trimetazidine and drugs producing a shift towards preferential glucose oxidation would also be a consideration. A number of studies stress that they may produce an improvement in ischemic cardiomyopathy, probably through an anti-inflammatory action.261... [Pg.181]

Much research has been conducted on the etiology of valvular dysfunction and the optimal timing for treatment. Pharmacologic treatment of valvular diseases with beta-blockers, ACE inhibitors, angiotensin receptor blockers and HMG-CoA reductase inhibitors can improve symptoms but has not been shown to effectively prolong survival. Thus, the treatment of choice for... [Pg.123]

The rationale for the use of oral vasodilator drugs in the pharmacotherapy of CHF derived from the experience with the parenteral agents phentolamine and nitroprusside in patients with severe heart failure and elevated systemic vascular resistance. Although a number of vasodilators may improve symptoms in heart failure, only the hydralazine-isosorbide dinitrate combination and antagonists of the renin-angiotensin system (ACE inhibitors and ATj receptor blockers) have been shown to improve survival in prospective randomized trials. Table 33-1 summarizes some properties of vasodilators used to treat heart failure. [Pg.566]

Beta blockers ACE inhibitors Alpha blockers Angiotensin II receptor antagonists Calcium-channel blockers Dihydrofyridines Calcium-channel blockers Dikiazem Calcium-channel blockers Verapamil Clonidine Ketanserin Vasodilators... [Pg.881]

ACE, angiotensin-converting enzyme ARB, angiotensin receptor blocker ... [Pg.11]

See other pages where Angiotensin blockers/ACE is mentioned: [Pg.523]    [Pg.47]    [Pg.328]    [Pg.241]    [Pg.175]    [Pg.36]    [Pg.461]    [Pg.493]    [Pg.429]    [Pg.68]    [Pg.400]    [Pg.196]    [Pg.279]    [Pg.291]    [Pg.289]    [Pg.125]    [Pg.1471]    [Pg.382]    [Pg.77]    [Pg.400]    [Pg.250]    [Pg.23]    [Pg.132]    [Pg.140]    [Pg.142]    [Pg.396]    [Pg.26]    [Pg.32]    [Pg.47]    [Pg.13]   


SEARCH



ACE

© 2024 chempedia.info